Aperio Group’s Axogen AXGN Stock Holding History

Aperio Group’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,884	Closed	-$77K	–	2346
2019 Q2	$77K	Buy	+3,884	New	+$83.1K	﹤0.01%	2456
2018 Q4	–	Sell	-12,670	Closed	-$467K	–	2292
2018 Q3	$467K	Sell	12,670 -1,885	-13%	-$82.3K	﹤0.01%	1802
2018 Q2	$731K	Sell	14,555 -277	-2%	-$12.2K	﹤0.01%	1550
2018 Q1	$541K	Buy	14,832 +257	+2%	+$7.88K	﹤0.01%	1661
2017 Q4	$412K	Buy	+14,575	New	+$344K	﹤0.01%	1790

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aperio Group's AXGN Position: Q3 2019 in Review

Aperio Group sold out of Axogen (AXGN) in Q3 2019, closing a stake of 3,884 shares — an estimated $77K sold.

Aperio Group first reported a position in AXGN in Q4 2017 and held it in 5 quarters. The position peaked at $731K in Q2 2018. 125 funds tracked by Wall St. Rank hold AXGN as of Q3 2019.

Aperio Group reported no remaining Axogen position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 3,884 Axogen shares in Q3 2019, an estimated $77K.
Aperio Group first reported a position in Axogen in Q4 2017 and held it in 5 quarters.
Aperio Group's Axogen position peaked at $731K in Q2 2018.
125 funds tracked by Wall St. Rank held Axogen as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.